International Assets Investment Management LLC Makes New $100,000 Investment in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

International Assets Investment Management LLC bought a new stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,669 shares of the company’s stock, valued at approximately $100,000. International Assets Investment Management LLC owned approximately 0.11% of Global X Genomics & Biotechnology ETF as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of GNOM. Archford Capital Strategies LLC increased its position in Global X Genomics & Biotechnology ETF by 15.6% during the fourth quarter. Archford Capital Strategies LLC now owns 23,076 shares of the company’s stock worth $267,000 after purchasing an additional 3,107 shares during the last quarter. Stratos Wealth Partners LTD. increased its holdings in shares of Global X Genomics & Biotechnology ETF by 9.3% during the 3rd quarter. Stratos Wealth Partners LTD. now owns 39,001 shares of the company’s stock worth $397,000 after buying an additional 3,327 shares during the last quarter. Oppenheimer Asset Management Inc. raised its position in shares of Global X Genomics & Biotechnology ETF by 11.5% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 54,114 shares of the company’s stock valued at $550,000 after buying an additional 5,598 shares during the period. Raymond James Financial Services Advisors Inc. lifted its holdings in Global X Genomics & Biotechnology ETF by 9.0% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 250,986 shares of the company’s stock valued at $2,901,000 after acquiring an additional 20,812 shares during the last quarter. Finally, One Capital Management LLC grew its position in Global X Genomics & Biotechnology ETF by 4.6% in the third quarter. One Capital Management LLC now owns 540,278 shares of the company’s stock worth $5,495,000 after acquiring an additional 23,889 shares during the period. 56.95% of the stock is owned by institutional investors and hedge funds.

Global X Genomics & Biotechnology ETF Stock Up 2.0 %

GNOM stock opened at $10.00 on Tuesday. Global X Genomics & Biotechnology ETF has a 52-week low of $8.63 and a 52-week high of $13.33. The stock has a market cap of $91.20 million, a price-to-earnings ratio of -4.27 and a beta of 1.03. The business has a fifty day moving average of $11.11 and a two-hundred day moving average of $10.80.

Global X Genomics & Biotechnology ETF Profile

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.